Zhitong Finance and Economics APP News, China Meheco Group (600056.SH) issued an announcement. Recently, its wholly-owned subsidiary Tianfang Pharmacy Co., Ltd. (referred to as "Tianfang Pharmacy") received two approval notices of supplementary application for the production of Tomoxetine Hydrochloride Capsules issued by the National Medical Products Administration, which passed the consistency evaluation of generic drug quality and efficacy.

Tomoxetine Hydrochloride Capsules are used to treat attention deficit/hyperactivity disorder (ADHD) in children and adolescents. The original research product is currently imported domestically. According to relevant national policies, drug varieties that pass consistency evaluation will receive greater support in areas such as medical insurance payments and procurement by medical institutions. The consistency evaluation of Tianfang Pharmacy's Tomoxetine Hydrochloride Capsules for generic drug quality and efficacy will help expand the market share of this drug. At the same time, it has accumulated valuable experience for the company to carry out consistency evaluation work for subsequent products.